Tom Parks

Imperial College London, UK, United Kingdom

This delegate is presenting an abstract at this event.

I am a Clinician Scientist funded by the Wellcome Trust with an interest in understanding how the genetics of the host influence susceptibility to infectious and inflammatory disease.

Presentations this author is a contributor to:

Antibody responses to Streptococcus pyogenes in UK adults over the COVID-19 pandemic period (#180)

5:30 PM

Amelia Lias

Poster Session 1

Rare deleterious variants and susceptibility to invasive group A streptococcal disease (118320)

10:15 AM

Tom Parks

Plenary 10 - Invasive Disease

Complement factor H and susceptibility to rheumatic heart disease (#229)

5:30 PM

Tom Parks

Poster Session 2

Identification of RNA Biomarkers for Acute Rheumatic Fever (ARF) (#259)

5:30 PM

Lara Oberski

Poster Session 2

Circulating prothymosin alpha and immunoglobulin G3 in acute rheumatic fever and rheumatic heart disease: A case control study (#255)

5:30 PM

Tom Parks

Poster Session 2

Immunization with Group A Carbohydrate (GAC) and the Induction of Crossreactive Autoantibodies (121914)

4:00 PM

Allan Saul

Concurrent 2a - Immunity, The Good, Bad, and Ugly

Tom Parks

Imperial College London, UK, United Kingdom

Antibody responses to Streptococcus pyogenes in UK adults over the COVID-19 pandemic period (#180)

Rare deleterious variants and susceptibility to invasive group A streptococcal disease (118320)

Complement factor H and susceptibility to rheumatic heart disease (#229)

Identification of RNA Biomarkers for Acute Rheumatic Fever (ARF) (#259)

Circulating prothymosin alpha and immunoglobulin G3 in acute rheumatic fever and rheumatic heart disease: A case control study (#255)

Immunization with Group A Carbohydrate (GAC) and the Induction of Crossreactive Autoantibodies (121914)

Contact Tom Parks

Login